Theodore Alkousakis

Dermatology
1665 Aurora Ct
Aurora, CO 80045

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study.

The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study.

Journal: Dermatology and therapy
Published: December 19, 2025

SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement.

SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement.

Journal: The British journal of dermatology
Published: July 14, 2025

Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.

Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial.

Journal: JAMA dermatology
Published: June 25, 2025

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.

Journal: JAMA dermatology
Published: June 25, 2025

Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry.

Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry.

Journal: Dermatology and therapy
Published: April 28, 2025

Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement.

Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement.

Journal: JAMA dermatology
Published: December 11, 2024

Flagellate Shiitake Mushroom Reaction With Histologic Features of Acute Generalized Exanthematous Pustulosis.

Flagellate Shiitake Mushroom Reaction With Histologic Features of Acute Generalized Exanthematous Pustulosis.

Journal: Cutis
Published: November 26, 2021

A review of non-pharmacologic approaches to enhance the patient experience in dermatologic surgery.

A review of non-pharmacologic approaches to enhance the patient experience in dermatologic surgery.

Journal: Dermatology online journal
Published: May 04, 2020

Remote-onset alopecia areata attributed to ipilimumab.

Remote-onset alopecia areata attributed to ipilimumab.

Journal: Cutis
Published: January 16, 2020

Gender differences in melanoma prognostic factors.

Gender differences in melanoma prognostic factors.

Journal: Dermatology online journal
Published: June 12, 2018

Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review.

Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review.

Journal: Journal of drugs in dermatology : JDD
Published: March 15, 2018

Topical 5-fluorouracil in dermatologic disease.

Topical 5-fluorouracil in dermatologic disease.

Journal: International journal of dermatology
Published: February 03, 2018
Showing 1-12 of 16

Last Updated: 04/28/2026